Tesalin® – Ze 339
Tesalin® – Ze 339
Treatment of allergic rhinitis (hay-fever).
- Anti-allergic and anti-inflammatory
- Non-inferiority to anti-histamines
- No drowsiness or fatigue
This is an authorised medicinal product.
Max Zeller Söhne AG, 8590 Romanshorn
Product information
Indication
For the treatment of intermittent (seasonal) allergic rhinitis and related symptoms of the eyes, nose and throat
Extract composition
17.8 - 40 mg CO2 extract (Ze 339) from the leaves of Petasites hybridus, standardized to 8 mg petasins
Drug-extract ratio (DER): 50-100:1
Patented sub-critical CO2 extraction
Dosage
2-3 x 1 film-coated tablets per day.
Clinical Evidence & Mode of action
The information contained in this section is intended for healthcare professionals only.
Please click the button below to confirm that you are a healthcare professional.
Get in Touch
Max Zeller Soehne AG Seeblickstr. 4 8590 Romanshorn Switzerland
Ze 339 – The Difference
New Herbal Entity – Ze 339 is the first Petasites hybridus leaf extract for the treatment of allergic rhinitis, with no similar product worldwide
Dual action – Alleviates broad range of allergic rhinitis complaints including allergic (rhinorrhea, itching etc.) and inflammatory symptoms (nasal congestion) by inhibiting synthesis of leukotrienes and release of various inflammatory mediators
Highly effective - Proven equal efficacy in head-to-head trials with antihistamines
Excellent safety & tolerability – Low incidence of adverse effects and no sedative effect
